{"id":12587,"date":"2024-10-11T19:01:10","date_gmt":"2024-10-11T17:01:10","guid":{"rendered":"https:\/\/valintermed.com\/?p=12587"},"modified":"2024-10-11T19:01:10","modified_gmt":"2024-10-11T17:01:10","slug":"polikistoznaya-lipomembranoznaya-osteodisplaziya-so-skleroziruyuschey-leykoentsefalopatiey","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/polycystic-lipomembranous-osteodysplasia-with-sclerosing-leukopenia\/","title":{"rendered":"Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy"},"content":{"rendered":"
<\/div>\n

Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLMOSD) is a rare hereditary disease characterized by hydrocele (cysts) in bone tissue and severe sclerosing leukoencephalopathy, which leads to severe disorders of the central nervous system. The pathology has a complex nature and is accompanied by multiple clinical manifestations, including skeletal deformities, neurological disorders and metabolic disorders. The leading cause is a genetic mutation affecting the development of bone tissue and the brain. This disease is the subject of active study in the field of medical genetics and neurology, which allows improving diagnostic and treatment methods.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n